[Ip-health] Statement by MSF on the conclusion of TPP negotiations in Atlanta

[Judit Rius]

Statement by MSF on the conclusion of TPP negotiations in Atlanta

Statement by Judit Rius Sanjuan, US Manager & Legal Policy Adviser, MSF 
Access Campaign:
 
"MSF expresses its dismay that TPP countries have agreed to United States 
government and multinational drug company demands that will raise the 
price of medicines for millions by unnecessarily extending monopolies and 
further delaying price-lowering generic competition. The big losers in the 
TPP are patients and treatment providers in developing countries. Although 
the text has improved over the initial demands, the TPP will still go down 
in history as the worst trade agreement for access to medicines in 
developing countries, which will be forced to change their laws to 
incorporate abusive intellectual property protections for pharmaceutical 
companies.

For example, the additional monopoly protection provided for biologic 
drugs will be a new regime for all TPP developing countries. These 
countries will pay a heavy price in the decades to come that will be 
measured in the impact it has on patients.  As the trade agreement now 
goes back to the national level for countries's final approval, we urge 
all governments to carefully consider before they sign on the dotted line 
whether this is the direction they want to take on access to affordable 
medicines and the promotion of biomedical innovation. The negative impact 
of the TPP on public health will be enormous, be felt for years to come 
and it will not be limited to the current 12 TPP countries, as it is a 
dangerous blueprint for future agreements."

http://msfaccess.org/about-us/media-room/press-releases/statement-msf-conclusion-tpp-negotiations-atlanta


Judit Rius Sanjuan
U.S. Manager & Legal Policy Adviser, Access Campaign
Medecins Sans Frontieres/ Doctors Without Borders (MSF)
333 7th Avenue, 2nd Floor
New York, NY 10001 USA
Office: +1 212 655 3762 // Mobile: +1 917 331 9077
Email: judit.rius at newyork.msf.org // Twitter: juditrius